386 related articles for article (PubMed ID: 7747469)
21. Genetic analysis of growth inhibition by GAL4-L kappa B-alpha in Saccharomyces cerevisiae.
Morin PJ; Downs JA; Snodgrass AM; Gilmore TD
Cell Growth Differ; 1995 Jul; 6(7):789-98. PubMed ID: 7547500
[TBL] [Abstract][Full Text] [Related]
22. Concerted activity of host cell factor subregions in promoting stable VP16 complex assembly and preventing interference by the acidic activation domain.
LaBoissière S; Walker S; O'Hare P
Mol Cell Biol; 1997 Dec; 17(12):7108-18. PubMed ID: 9372942
[TBL] [Abstract][Full Text] [Related]
23. Alterations in a yeast protein resembling HIV Tat-binding protein relieve requirement for an acidic activation domain in GAL4.
Swaffield JC; Bromberg JF; Johnston SA
Nature; 1992 Jun; 357(6380):698-700. PubMed ID: 1614516
[TBL] [Abstract][Full Text] [Related]
24. The PDX-1 activation domain provides specific functions necessary for transcriptional stimulation in pancreatic beta-cells.
Peshavaria M; Cissell MA; Henderson E; Petersen HV; Stein R
Mol Endocrinol; 2000 Dec; 14(12):1907-17. PubMed ID: 11117522
[TBL] [Abstract][Full Text] [Related]
25. The neuroendocrine protein 7B2 contains unusually potent transcriptional activating sequences.
Chaudhuri B; Huijbregts RP; Coen JJ; Fürst P
Biochem Biophys Res Commun; 1995 Nov; 216(1):1-10. PubMed ID: 7488073
[TBL] [Abstract][Full Text] [Related]
26. DNA recognition by the herpes simplex virus transactivator VP16: a novel DNA-binding structure.
Babb R; Huang CC; Aufiero DJ; Herr W
Mol Cell Biol; 2001 Jul; 21(14):4700-12. PubMed ID: 11416146
[TBL] [Abstract][Full Text] [Related]
27. Transcriptional activation by human c-myb and v-myb genes.
Kalkbrenner F; Guehmann S; Moelling K
Oncogene; 1990 May; 5(5):657-61. PubMed ID: 2189102
[TBL] [Abstract][Full Text] [Related]
28. Direct and selective binding of an acidic transcriptional activation domain to the TATA-box factor TFIID.
Stringer KF; Ingles CJ; Greenblatt J
Nature; 1990 Jun; 345(6278):783-6. PubMed ID: 2193231
[TBL] [Abstract][Full Text] [Related]
29. The herpes simplex virus trans-activator VP16 recognizes the Oct-1 homeo domain: evidence for a homeo domain recognition subdomain.
Stern S; Herr W
Genes Dev; 1991 Dec; 5(12B):2555-66. PubMed ID: 1684335
[TBL] [Abstract][Full Text] [Related]
30. Activation domains for controlling plant gene expression using designed transcription factors.
Li J; Blue R; Zeitler B; Strange TL; Pearl JR; Huizinga DH; Evans S; Gregory PD; Urnov FD; Petolino JF
Plant Biotechnol J; 2013 Aug; 11(6):671-80. PubMed ID: 23521778
[TBL] [Abstract][Full Text] [Related]
31. The transactivator proteins VP16 and GAL4 bind replication factor A.
He Z; Brinton BT; Greenblatt J; Hassell JA; Ingles CJ
Cell; 1993 Jun; 73(6):1223-32. PubMed ID: 8513504
[TBL] [Abstract][Full Text] [Related]
32. The herpesvirus transactivator VP16 mimics a human basic domain leucine zipper protein, luman, in its interaction with HCF.
Lu R; Yang P; Padmakumar S; Misra V
J Virol; 1998 Aug; 72(8):6291-7. PubMed ID: 9658067
[TBL] [Abstract][Full Text] [Related]
33. Transcriptional activation by herpes simplex virus type 1 VP16 in vitro and its inhibition by oligopeptides.
Wu TJ; Monokian G; Mark DF; Wobbe CR
Mol Cell Biol; 1994 May; 14(5):3484-93. PubMed ID: 8164693
[TBL] [Abstract][Full Text] [Related]
34. A single amino acid exchange transfers VP16-induced positive control from the Oct-1 to the Oct-2 homeo domain.
Lai JS; Cleary MA; Herr W
Genes Dev; 1992 Nov; 6(11):2058-65. PubMed ID: 1358756
[TBL] [Abstract][Full Text] [Related]
35. Agonist and antagonists induce homodimerization and mixed ligand heterodimerization of human progesterone receptors in vivo by a mammalian two-hybrid assay.
Leonhardt SA; Altmann M; Edwards DP
Mol Endocrinol; 1998 Dec; 12(12):1914-30. PubMed ID: 9849965
[TBL] [Abstract][Full Text] [Related]
36. Analysis of the DNA binding and transcriptional activation properties of the Ets1 oncoprotein.
Gegonne A; Punyammalee B; Rabault B; Bosselut R; Seneca S; Crabeel M; Ghysdael J
New Biol; 1992 May; 4(5):512-9. PubMed ID: 1515415
[TBL] [Abstract][Full Text] [Related]
37. Weak transcriptional activation is sufficient for transformation by v-Myb.
Engelke U; Whittaker L; Lipsick JS
Virology; 1995 Apr; 208(2):467-77. PubMed ID: 7747419
[TBL] [Abstract][Full Text] [Related]
38. Interdigitated residues within a small region of VP16 interact with Oct-1, HCF, and DNA.
Lai JS; Herr W
Mol Cell Biol; 1997 Jul; 17(7):3937-46. PubMed ID: 9199328
[TBL] [Abstract][Full Text] [Related]
39. The acidic transcriptional activation domains of herpes virus VP16 and yeast HAP4 have different co-factor requirements.
Wang L; Turcotte B; Guarente L; Berger SL
Gene; 1995 Jun; 158(2):163-70. PubMed ID: 7607537
[TBL] [Abstract][Full Text] [Related]
40. Transcriptional activation by TFIIB mutants that are severely impaired in interaction with promoter DNA and acidic activation domains.
Chou S; Struhl K
Mol Cell Biol; 1997 Dec; 17(12):6794-802. PubMed ID: 9372910
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
